نتائج البحث

Maintenance Chemotherapy With S-1, Locally Advanced Esophageal Cancer Receiving Definitive CCRT

• Authors : Ming-Yu Lien, M.D Ph.D

• Source: Phase II Study of Maintenance Chemotherapy With S-1 in Patients With Locally Advanced Esophageal Cancer Receiving Definitive Concurrent Chemoradiotherapy

تفاصيل العنوان

To Observe the Benefit of Adding Brachytherapy After CCRT on Resectable Esophageal Cancer Patients Without Surgery

• Source: To Observe the Local Tumor Recurrence Rate of Adding Intraluminal Brachytherapy With Balloon Applicator After Standard Definitive Concurrent Chemoradiotherapy (CCRT) on

تفاصيل العنوان

Serplulimab Combined With CCRT for LS-SCLC.

• Source: A Single-arm Phase II Clinical Trial of Serplulimab Combined With Concurrent Chemoradiotherapy for Limited-stage Small Cell Lung Cancer(LS-SCLC).

تفاصيل العنوان

Safety & Efficacy of Peg-ASP-based CCRT in Early Stage ENKTL (ENKTL)

• Authors : Hua Wang, Associate senior doctor

• Source: Evaluate the Safety and Efficacy of Pegaspargase-based Concurrent Chemoradiotherapy in the Treatment of Early Stage Extranodal NK/T Cell Lymphoma

تفاصيل العنوان

Postoperative CCRT With Docetaxel vs Cisplatin in High Risk Oral Cavity Cancer

• Authors : Guopei Zhu, MD

• Source: Postoperative Radiation and Concurrent Chemotherapy With Weekly Docetaxel Versus Cisplatin in Patients With High-risk Oral Cavity Cancer: a Randomized Phase II Clinical Trial

تفاصيل العنوان

Using Microbiome to Predict Durvalumab Toxicity in Post- Concurrent Chemoradiation Therapy (CCRT) NSCLC Patients (Microdurva)

• Authors : Rhode Island Hospital; Jun Zhang, MD, PhD, MD, PhD

• Source: Using Microbiome to Predict Durvalumab Toxicity in Post-CCRT NSCLC Patients (Microdurva)Swami U, Zakharia Y, Zhang J. Understanding Microbiome Effect on Immune

تفاصيل العنوان

Toripalimab Combined With Definitive CCRT for LACC Patients

• Authors : Haoping Xu, Prof

• Source: Toripalimab Combined With Definitive Chemoradiotherapy for Locally Advanced Cervical Squamous Cell Carcinoma Patients

تفاصيل العنوان

Neoadjuvant CCRT With Gemcitabine/Durvalumab (MEDI4736) Followed by Adjuvant Gemcitabine/Durvalumab(MEDI4736) in Resectable or Borderline Resectable Pancreatic Cancer

• Authors : AstraZeneca; Do-Youn Oh, Professor

• Source: Neoadjuvant CCRT With Gemcitabine/Durvalumab (MEDI4736) Followed by Adjuvant Gemcitabine/Durvalumab(MEDI4736) in Resectable or Borderline Resectable Pancreatic Cancer

تفاصيل العنوان

Impact of pretreatment quality of life on tolerance and survival outcome in head and neck cancer patients undergoing definitive CCRT

• Authors : Chia-Yen Hung; Mei-Hui Hsu; Shu‐Hui Lee

Subjects: Concurrent chemoradiotherapy; Head and neck cancer; Prognosis

• Source: Journal of the Formosan Medical Association, Vol 123, Iss 9, Pp 1010-1017 (2024)

تفاصيل العنوان

A Study to Evaluate the Efficacy and Safety of TJ107 in Lympopenic Patients With Newly Diagnosed Glioblastoma Who Completed Standard Concurrent Chemoradiotherapy (CCRT)

• Source: A Phase 2, Randomized, Single-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TJ107 in Lympopenic Patients With Newly Diagnosed Glioblastoma Who Completed Standard Concurrent

تفاصيل العنوان